Prophylactic treatment of migraine headache and histamine cephalalgia with a serotonin antagonist (methysergide).

No abstract is available for this paper.

• Publication year

  1961

• Venue

  Annals of allergy

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 13711763
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of serotonin in migraine patients

  1960cited by this paper
• Use of a new compound, UML-491 (1-methyl-D-lysergic acid butanolamide), in the prevention of various types of headache.

  1960cited by this paper
• Prophylactic and therapeutic properties of 1-methyl-lysergic acid butanolamide in migraine.

  1959cited by this paper
• Comparison of lysergic acid derivatives and antihistamines as inhibitors of the edema provoked in the rat's paw by serotonin.

  1958cited by this paper
• Studies in headache; summary of evidence concerning a noxious agent active locally during migraine headache.

  1957cited by this paper
• The identification of 5-hydroxy-3-indoleacetic acid in normal urine and a method for its assay.

  1955cited by this paper
• The estimation of 5-hydroxytryptamine (serotonin) in biological tissues.

  1955cited by this paper

• Hallmarks of primary headache: part 3 – cluster headache

  2025cites this paper
• Inhibition of spleen tyrosine kinase attenuates allergen-mediated airway constriction.

  2013cites this paper
• Management of Trigeminal Autonomic Cephalgias and Hemicrania Continua

  2012cites this paper
• History of Methysergide in Migraine

  2008cites this paper
• Methysergide

  1998cites this paper
• INTRACUTANEOUS SEROTONIN TEST IN DYSTHYROID AND NORMAL PERSONS

  1969cites this paper
• Methysergide in prophylaxis of migraine: a clinical trial in general practice.

  1966cites this paper
• Methysergide in migraine prophylaxis

  1966cites this paper
• MIGRAINOUS NEURALGIA

  1966cites this paper
• CLINICAL STUDIES ON THE TREATMENT OF VASCULAR HEADACHES, A PROGRESS REPORT ON METHYSERGIDE (SANSERT®)

  1965cites this paper
• Total plasma serotonin, 5-hydroxyindoleacetic acid and p-hydroxy-m-methoxymandelic acid excretion in normal and migrainous subjects.

  1965cites this paper
• Clinical trial of methysergide and other preparations in the management of migraine

  1964cites this paper
• METHYSERGIDE IN THE PROPHYLAXIS OF MIGRAINE.

  1964cites this paper
• Methysergide in the migraine syndrome

  1964cites this paper
• An evaluation of methysergide in the prevention of migraine and other vascular headaches.

  1963cites this paper
• USE OF METHYSERGIDE IN THE TREATMENT OF EXTRACRANIAL VASCULAR HEADACHE

  1963cites this paper
• Acute ischemia of a limb complicating methysergide maleate therapy.

  1963cites this paper
• Vasodilating headache: a suggested classification and results of prophylactic treatment with UML 491 (methysergide).

  1962cites this paper
• [Serotonin and its antagonists].

  1962cites this paper
• TREATMENT OF MIGRAINE, HORTON'S SYNDROME AND RESTLESS LEGS WITH DESERIL (UML–491)

  1962cites this paper